That would be nice. I'm a little concerned about n
Post# of 736
He that is trustworthy in small things is more likely to be trustworthy in large things.
If they can't get their ducks in a row enough to get the OTC current status back (it's been a couple months now), that is not a good indicator for making an acquisition as a public company.
I own a lot of this one, and am very optimistic about the future. I think that Christopher has more than he can deal with by himself, and doesn't have the revenue to bring on help. I hope he is able to pull through for the company in the next few weeks so that can change.
I will say that I am very happy that he doesn't seem the least bit interested in the day to day stock price. I've seen no real evidence of pumping or any other shady OTC behavior from him. He is acting exactly like a serious businessman starting from scratch.
I hope he continues to largely ignore shareholder pleas for updates and information, and instead focuses on executing. If he is able to complete the acquisition and become a company with revenue of 4 to 6 million annually, that should value this stock between .0008 and .0011.